Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective

ABSTRACT: Autologous stem cell transplantation (ASCT) is a well-established approach to treatment of patients with relapsed/refractory (R/R) Hodgkin lymphoma (HL) recommended by both the European Society for Medical Oncology and the National Comprehensive Cancer Network based on the results from ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Sureda, Anna, André, Marc, Borchmann, Peter, da Silva, Maria G., Gisselbrecht, Christian, Vassilakopoulos, Theodoros P., Zinzani, Pier Luigi, Walewski, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657361/
https://www.ncbi.nlm.nih.gov/pubmed/33172440
http://dx.doi.org/10.1186/s12885-020-07561-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657361/
https://www.ncbi.nlm.nih.gov/pubmed/33172440
http://dx.doi.org/10.1186/s12885-020-07561-2

Ejemplares similares